Evidence map›Paper›PMID 41317266›Full record

ArticleDiscover oncology2025

Molecular signatures under hexavalent chromium, particulate matter 2.5, and cigarette smoking exposures.

Yun-Xia Xie, Guang-Qi Li, Xiao-Nan Wang, Wen-Wen Ran

Abstract read
In one paragraph

Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yun-Xia XieDepartment of Pathology, The Affiliated Hospital of Qingdao University, Qingdao, 266000, Shandong, China.
Guang-Qi LiDepartment of Pathology, The Affiliated Hospital of Qingdao University, Qingdao, 266000, Shandong, China.
Xiao-Nan WangDepartment of Pathology, The Affiliated Hospital of Qingdao University, Qingdao, 266000, Shandong, China.
Wen-Wen RanDepartment of Pathology, The Affiliated Hospital of Qingdao University, Qingdao, 266000, Shandong, China. rww007@163.com.

Funding

Qingdao University Hospital Youth Research Fund QDFYQN2024114
6 · The paper itself

Abstract

Exposure to air environment pollutants is one of the leading causes of lung cancer. To date, no relevant studies have compared the molecular signatures under exposure to lung cancer-related public air pollution, occupational exposure and personal pollutants, including hexavalent chromium [Cr(VI)], particulate matter 2.5 (PM2.5) and cigarette smoking. In this study, we conducted the Weighted gene co-expression network analysis (WGCNA) to identify the key modules under pollutant exposure, and used Mfuzz analysis to discover dose- or time-dependent gene sets. Pathway enrichment analysis and differentially expressed gene analysis were utilized to identify pollutant-induced signature genes. The results showed that the PI3K–AKT pathway is the most significantly upregulated pathway in Cr(VI) exposure, with significant upregulation observed in the genes CCND1, GDNF, IL7R, ITGA4, KIT, and PRKAA2. We found that PM2.5 activated the growth factor receptor binding pathway, significantly upregulating the expression of the proteins IL1A, TGFA and PDGFA on this pathway with increasing treatment time and dosage.Furthermore, cigarette smoking exposure activated MAPK cascade pathway and growth factor activity and the key genes ACTA2, FGF2, ROR2, FGF21, INHBE and MDK levels were elevated with increasing exposure duration. Our study delineates the molecular landscapes under three environmental pollutants and reveals the molecular mechanisms underlying the induction of malignant cell transformation by different environmental pollutants.

Indexed as

Cigarette smokingHexavalent chromiumMolecular characteristicsParticulate matter 2.5

Identifiers

PMID41317266
PMCPMC12770133

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.